Towards Healthcare
Chronic Disease Treatment Market Grows to USD 9.74 Billion in 2025

Chronic Disease Treatment Market Expands in 2025 With Focus on Diabetes, Digital Health and Home-Based Care

Based on market forecasts, the global chronic disease treatment market, projected at USD 8.37 billion in 2024, is expected to reach USD 38.02 billion by 2034, growing at a CAGR of 16.34% over the forecast period.The rising prevalence of chronic disorders and growing research and development activities boost the market. Favorable regulatory policies and a robust healthcare infrastructure contribute to North America’s dominance.

Content

  • Insight Code: 5826
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The chronic disease treatment market is projected to reach USD 38.02 billion by 2034, growing at a CAGR of 16.34% from 2025 to 2034.

North America is leading the chronic disease treatment market due to favorable regulatory policies, state-of-the-art research and development facilities, and a robust healthcare infrastructure.

The chronic disease treatment market includes six segments such as by disease type, by treatment type, by drug class, by care delivery model, by end-user, and by region.

Some key players include Pfizer, Inc., Novartis AG, and Johnson & Johnson.

Key trends include the rising prevalence of chronic diseases, the growing geriatric population, and technological advancements.

The symptoms of chronic diseases can be managed through medications, lifestyle changes, diet, and exercise.

The primary purpose of chronic disease management is to help patients self-identify an irregularity before the condition progresses to a life-threatening or highly debilitating level.

World Health Organization, Food and Drug Administration, National Medical Products Administration, European Medicines Agency
Any Questions